
5.60 Delayed Data As of Aug 05 | ![]() Today’s Change | 4.00 Today|||52-Week Range 29.59 | -79.72% Year-to-Date |
Supernus Pharmaceuticals (SUPN) Q2 Earnings Lag Estimates Aug 04 / Zacks.com - Paid Partner Content | Bausch Health (BHC) Dips More Than Broader Markets: What You Should Know Aug 01 / Zacks.com - Paid Partner Content |
Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates Aug 03 / Zacks.com - Paid Partner Content | Bausch (BHC) Loses 39% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Jul 29 / Zacks.com - Paid Partner Content |
What's in the Cards for Bausch Health (BHC) Q2 Earnings? Aug 02 / Zacks.com - Paid Partner Content | Why Shares of Bausch Health Companies Dropped 54.4% This Week Jul 28 / MotleyFool.com - Paid Partner Content |
Analysts Estimate Bausch Health (BHC) to Report a Decline in Earnings: What to Look Out for Aug 02 / Zacks.com - Paid Partner Content |
Previous close | 5.12 |
Today’s open | 5.05 |
Day’s range | 4.96 - 5.68 |
Volume | 9,746,204 |
Average volume (3 months) | 7,447,950 |
Market cap | -- |
Earnings growth (last year) | -67.44% |
Earnings growth (this year) | -10.42% |
Earnings growth (next 5 years) | +4.85% |
Revenue growth (last year) | +5.07% |
P/E ratio | NM |
Price/Sales | 1.17 |
Price/Book | -- |
---- | ||
KRYSKrystal Biotech Inc | +3.62 | +4.61% |
---- | ||
--Almirall SA | 0.00 | 0.00% |
Next reporting date | August 9, 2022 |
EPS forecast (this quarter) | $0.91 |
Annual revenue (last year) | $8.4B |
Annual profit (last year) | -$948.0M |
Net profit margin | -11.24% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Laval, Quă©bec |